Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pseudomyxoma Peritonei × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 75 Neoplasms 66 Prostatic Neoplasms 51 Colorectal Neoplasms 43 Lung Neoplasms 38 Carcinoma, Non-Small-Cell Lung 28 Pancreatic Neoplasms 21 Hematologic Neoplasms 21 Neoplasm Metastasis 19 Head and Neck Neoplasms 19 Urinary Bladder Neoplasms 15 Ovarian Neoplasms 15 Multiple Myeloma 15 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Motor Activity 11 Leukemia, Myeloid, Acute 11 Glioblastoma 10 Uterine Cervical Neoplasms 9 Triple Negative Breast Neoplasms 9 Gastrointestinal Neoplasms 9 Colonic Neoplasms 9 Melanoma 8 Hematopoietic and Lymphatic System Neoplasm 8 Glioma 8 Esophageal Neoplasms 8 Carcinoma, Renal Cell 8 COVID-19 8 Anxiety Disorders 8 Anatomic Stage I Breast Cancer AJCC v8 8

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 3 Surveys and Questionnaires 2 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Capecitabine 2 Bromelains 2 Acetylcysteine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 cryoprecipitate coagulum 1 Tacrolimus 1 Standard of Care 1 Specimen Handling 1 Sirolimus 1 Referral and Consultation 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Observation 1 Nivolumab 1 Methods 1 Magnetic Resonance Spectroscopy 1 Lansoprazole 1 Ipilimumab 1 Ifosfamide 1 Gemcitabine 1 Floxuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04024917 2026-01-16

COCOON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Peritoneal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡